Material and Bio interface

Material and Biointerface (MBI) is a biotechnology company specializing in advanced surface modification technologies for medical devices and biosensors. The company leverages its proprietary zwitterionic material platform, specifically poly(carboxybetaine) (PCB), to create ultra-low fouling surfaces that prevent protein adsorption and bacterial attachment. These technologies are critical for enhancing the performance and biocompatibility of continuous glucose monitors (CGM), vascular catheters, and various surgical implants by reducing the foreign body response. MBI operates as both a technology provider for major medical device manufacturers and a developer of its own specialized medical components, aiming to improve long-term device functionality and patient outcomes.